Recent trends and harmonization of quality risk management
Keywords: Pharmaceutical quality system, quality risk management, critical parameter, GMP, WHO
AbstractThe World Health Organization (WHO) of the United Nations finalized the Annex 2 of the new technical Report 981 that is called as WHO guideline on the implementation of a Quality Management System, in July 2013. WHO requirements with the harmonized guidelines concern with harmonized European, US and Asian regulations. This article includes the role of Quality Risk Management in pharmaceutical quality system.
Download data is not yet available.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).